Polypharmacy and deprescribing in older adults

W Thompson, EG McDonald - Annual Review of Medicine, 2024 - annualreviews.org
Older adults commonly end up on many medications. Deprescribing is an important part of
individualizing care for older adults. It is an opportunity to discuss treatment options and …

Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future

A Mari, E Marabotto, M Ribolsi, F Zingone… - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Proton pump inhibitors (PPIs) have revolutionized the management
of acid-related disorders, representing today the mainstay treatment of these conditions …

Barriers and facilitators of implementing proactive deprescribing within primary care: a systematic review

DA Okeowo, STR Zaidi, B Fylan… - International Journal of …, 2023 - academic.oup.com
Objective Proactive deprescribing–identifying and discontinuing medicines where harms
outweigh benefits–can minimise problematic polypharmacy, but has yet to be implemented …

Barriers and enablers of older adults initiating a deprescribing conversation

NJ Ailabouni, KR Weir, E Reeve, JT Turner… - Patient Education and …, 2022 - Elsevier
Objective To examine older adults' perceptions and identify barriers and enablers to
initiating a conversation about stopping medication (s) with their healthcare provider …

Efficacy of a computer based discontinuation strategy to reduce PPI prescriptions: a multicenter cluster-randomized controlled trial

J Heisig, B Bücker, A Schmidt, AL Heye, A Rieckert… - Scientific Reports, 2023 - nature.com
Deprescribing of inappropriate long-term proton pump inhibitors (PPI) is challenging and
there is a lack of useful methods for general practitioners to tackle this. The objective of this …

Patient-reported barriers and enablers to deprescribing recommendations during a clinical trial (Shed-MEDS)

JL Kim, KM Lewallen, EK Hollingsworth… - The …, 2023 - academic.oup.com
Abstract Background and Objectives Effective deprescribing requires shared decision
making between a patient and their clinician, and should be used when implementing …

Deprescribing proton pump inhibitors

JP Turner, W Thompson, E Reeve… - Australian Journal of …, 2022 - search.informit.org
Background: Proton pump inhibitors (PPIs) are indicated for disorders including peptic ulcer
disease and gastro-oesophageal reflux disease; however, they are often used for longer …

Patients beliefs and attitudes towards deprescribing: can deprescribing success be predicted?

JP Turner, P Martin, YZ Zhang… - Research in Social and …, 2020 - Elsevier
Background The ability of questionnaires such as the Patients' Attitudes Towards
Deprescribing (PATD) or the Beliefs about Medicines Questionnaire (Specific section)(BMQ …

Holistic needs assessment in outpatient cancer care: a randomised controlled trial

A Snowden, J Young, D Roberge, S Schipani… - BMJ open, 2023 - bmjopen.bmj.com
Design Analyst blinded, parallel, multi-centre, randomised controlled trial (RCT). Participants
People with confirmed diagnoses of cancer (head and neck, skin or colorectal) attending …

Benzocarta: intervención mínima para la desprescripción de benzodiacepinas en pacientes con insomnio

M Baza Bueno, E Ruiz de Velasco Artaza… - Gaceta …, 2021 - SciELO Public Health
Objetivo Averiguar si una intervención mediante carta dirigida a usuarios de
benzodiacepinas consigue disminuir su consumo. Método Estudio antes-después sin grupo …